About Carmenta Bio
Carmenta Bio is a company based in Palo Alto (United States) founded in 2012 was acquired by Progenity in April 2015.. Carmenta Bio has raised $2.59 million across 2 funding rounds from investors including Progenity. Carmenta Bio operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Carmenta Bioscience Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Carmenta Bio
Carmenta Bio has successfully raised a total of $2.59M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.0M
-
First Round
First Round
(29 Jul 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2013 | Amount | Seed - Carmenta Bio | Valuation |
investors |
|
| Jul, 2013 | Amount | Seed - Carmenta Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Carmenta Bio
Carmenta Bio has secured backing from 1 investor. Prominent investors backing the company include Progenity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Carmenta Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Carmenta Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Carmenta Bio Comparisons
Competitors of Carmenta Bio
Carmenta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fertility decisions are optimized using data analytics and genomics.
|
|
| domain | founded_year | HQ Location |
Diagnostics and prognostics for maternal health are developed using metabolomics.
|
|
| domain | founded_year | HQ Location |
Provider of DNA and hormone analysis based birth control optimization kits
|
|
| domain | founded_year | HQ Location |
Disposable paper pregnancy test kits
|
|
| domain | founded_year | HQ Location |
Clinical-grade diagnostic tests for home use are developed.
|
|
| domain | founded_year | HQ Location |
Exosome-based diagnostic products for health screening are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Carmenta Bio
When was Carmenta Bio founded?
Carmenta Bio was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Carmenta Bio located?
Carmenta Bio is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Is Carmenta Bio a funded company?
Carmenta Bio is a funded company, having raised a total of $2.59M across 2 funding rounds to date. The company's 1st funding round was a Seed of $585.87K, raised on Jul 29, 2013.
What does Carmenta Bio do?
Carmenta Bio was founded in 2012 in Palo Alto, United States, as a Stanford spin-out focused on biotechnology for womens health. Proprietary computational algorithms were combined with protein sera measurements in its platform to enable maternal diagnostics. A diagnostic test for preeclampsia was offered for both symptomatic and asymptomatic expectant mothers. The company was acquired by Progenity in April 2015.
Who are the top competitors of Carmenta Bio?
Carmenta Bio's top competitors include Celmatix, Metabolomic Diagnostics and LIA Diagnostics.
Who are Carmenta Bio's investors?
Carmenta Bio has 1 investor. Key investors include Progenity.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.